Aimmune Therapeutics Inc (AIMT)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2020-10-15 | 2020-10-13 | B Purchase |
Societe des Produits Nestle S.A. Large shareholder |
10,681,704
+83.9%
34.50USD 368,518,788 |
10,681,704 +83.9% | 34.50 | USD 368,518,788 | |
| 2020-10-15 | 2020-10-13 | B Purchase |
Societe des Produits Nestle S.A. Large shareholder |
43,435,583
+inf%
34.50USD 1,498,527,614 |
43,435,583 +inf% | 34.50 | USD 1,498,527,614 | |
| 2020-03-19 | 2020-03-18 | B Purchase | Non-Executive Director |
16,213
+29.8%
11.06USD 179,345 |
16,213 +29.8% | 11.06 | USD 179,345 | |
| 2020-03-19 | 2020-03-17 | B Purchase | Non-Executive Director |
8,787
+19.3%
11.50USD 101,051 |
8,787 +19.3% | 11.50 | USD 101,051 | |
| 2020-03-19 | 2020-03-17 | B Purchase | Non-Executive Director |
100,000
+1.7%
11.40USD 1,139,650 |
100,000 +1.7% | 11.40 | USD 1,139,650 | |
| 2020-03-17 | 2020-03-13 | B Purchase |
Chief Commercial Officer Officer |
3,000
+13.6%
14.76USD 44,266 |
3,000 +13.6% | 14.76 | USD 44,266 | |
| 2020-03-12 | 2020-03-12 | B Purchase |
Chief Financial Officer Officer |
1,000
+2.4%
15.10USD 15,100 |
1,000 +2.4% | 15.10 | USD 15,100 | |
| 2020-03-10 | 2020-03-10 | B Purchase |
Dallas Jayson Donald Alexander President and CEO Executive Director |
2,665
+2.2%
18.74USD 49,934 |
2,665 +2.2% | 18.74 | USD 49,934 | |
| 2020-03-10 | 2020-03-09 | B Purchase |
Chief Financial Officer Officer |
1,000
+2.4%
18.97USD 18,970 |
1,000 +2.4% | 18.97 | USD 18,970 | |
| 2020-04-24 | 2020-02-07 | B Purchase |
Societe des Produits Nestle S.A. Large shareholder |
525,634
+inf%
319.68USD 168,032,049 |
525,634 +inf% | 319.68 | USD 168,032,049 | |
| 2020-04-24 | 2020-02-07 | B Purchase |
Societe des Produits Nestle S.A. Large shareholder |
1,000,000
+8.5%
31.97USD 31,970,000 |
1,000,000 +8.5% | 31.97 | USD 31,970,000 | |
| 2020-01-21 | 2020-01-16 | PS Planned sale |
See Remarks |
400
-0.9%
37.00USD 14,800 |
400 -0.9% | 37.00 | USD 14,800 | |
| 2020-01-03 | 2020-01-02 | PS Planned sale |
Chief Medical Officer |
20,000
-48.5%
35.00USD 700,038 |
20,000 -48.5% | 35.00 | USD 700,038 | |
| 2019-12-30 | 2019-12-26 | PS Planned sale |
Sheehy Douglas T. See Remarks Officer |
10,000
-18.0%
33.03USD 330,322 |
10,000 -18.0% | 33.03 | USD 330,322 | |
| 2019-12-11 | 2019-12-09 | PS Planned sale |
ADELMAN DANIEL C MD Chief Medical Officer Officer |
20,000
-48.5%
30.04USD 600,716 |
20,000 -48.5% | 30.04 | USD 600,716 | |
| 2019-09-20 | 2019-09-18 | B Purchase |
Chief Financial Officer |
1,550
+4.8%
22.57USD 34,977 |
1,550 +4.8% | 22.57 | USD 34,977 | |
| 2020-04-24 | 2018-11-28 | B Purchase |
Nestle Health Science US Holdings, Inc. Large shareholder |
3,237,529
+38.1%
30.27USD 98,000,003 |
3,237,529 +38.1% | 30.27 | USD 98,000,003 | |
| 2018-11-21 | 2018-11-19 | S Sale |
Barrowcliffe Susan E. General Manager, Europe Officer |
40,000
-81.0%
30.04USD 1,201,600 |
40,000 -81.0% | 30.04 | USD 1,201,600 | |
| 2018-11-19 | 2018-11-19 | B Purchase |
Dallas Jayson Donald Alexander President and CEO Executive Director |
50
+0.1%
27.56USD 1,378 |
50 +0.1% | 27.56 | USD 1,378 | |
| 2018-11-19 | 2018-11-19 | B Purchase |
Dallas Jayson Donald Alexander President and CEO Executive Director |
3,600
+6.0%
27.56USD 99,209 |
3,600 +6.0% | 27.56 | USD 99,209 | |
| 2018-06-14 | 2018-06-13 | PP Planned purchase |
Chief Financial Officer |
1,600
+8.9%
30.41USD 48,663 |
1,600 +8.9% | 30.41 | USD 48,663 | |
| 2018-06-13 | 2018-06-11 | PS Planned sale |
DILLY STEPHEN GEORGE President and CEO Executive Director |
29,457
-8.5%
30.83USD 908,301 |
29,457 -8.5% | 30.83 | USD 908,301 | |
| 2018-06-08 | 2018-06-08 | PS Planned sale |
DILLY STEPHEN GEORGE President and CEO Executive Director |
42,106
-11.8%
30.70USD 1,292,511 |
42,106 -11.8% | 30.70 | USD 1,292,511 | |
| 2018-06-08 | 2018-06-07 | PS Planned sale |
DILLY STEPHEN GEORGE President and CEO Executive Director |
500
-0.2%
31.58USD 15,790 |
500 -0.2% | 31.58 | USD 15,790 | |
| 2018-06-08 | 2018-06-07 | PS Planned sale |
DILLY STEPHEN GEORGE President and CEO Executive Director |
32,098
-9.2%
30.95USD 993,321 |
32,098 -9.2% | 30.95 | USD 993,321 | |
| 2018-06-08 | 2018-06-06 | PS Planned sale |
DILLY STEPHEN GEORGE President and CEO Executive Director |
30,465
-8.8%
31.20USD 950,371 |
30,465 -8.8% | 31.20 | USD 950,371 | |
| 2018-06-05 | 2018-06-05 | PS Planned sale |
DILLY STEPHEN GEORGE See Remarks Executive Director |
38,825
-11.0%
31.83USD 1,235,835 |
38,825 -11.0% | 31.83 | USD 1,235,835 | |
| 2018-06-05 | 2018-06-04 | PS Planned sale |
DILLY STEPHEN GEORGE See Remarks Executive Director |
2,612
-0.8%
32.74USD 85,519 |
2,612 -0.8% | 32.74 | USD 85,519 | |
| 2018-06-05 | 2018-06-04 | PS Planned sale |
DILLY STEPHEN GEORGE See Remarks Executive Director |
62,740
-16.5%
31.84USD 1,997,836 |
62,740 -16.5% | 31.84 | USD 1,997,836 | |
| 2018-06-05 | 2018-06-01 | PS Planned sale |
DILLY STEPHEN GEORGE See Remarks Executive Director |
2,498
-0.8%
33.19USD 82,899 |
2,498 -0.8% | 33.19 | USD 82,899 | |
| 2018-06-05 | 2018-06-01 | PS Planned sale |
DILLY STEPHEN GEORGE See Remarks Executive Director |
58,699
-15.6%
32.59USD 1,913,094 |
58,699 -15.6% | 32.59 | USD 1,913,094 | |
| 2018-05-24 | 2018-05-22 | PS Planned sale |
Sheehy Douglas T. See Remarks Officer |
1,648
-4.7%
33.00USD 54,384 |
1,648 -4.7% | 33.00 | USD 54,384 | |
| 2018-05-24 | 2018-05-22 | PS Planned sale |
Sheehy Douglas T. See Remarks Officer |
1,648
-4.7%
33.00USD 54,384 |
1,648 -4.7% | 33.00 | USD 54,384 | |
| 2018-03-06 | 2018-03-05 | PS Planned sale |
Sheehy Douglas T. See Remarks |
700
-2.1%
36.60USD 25,618 |
700 -2.1% | 36.60 | USD 25,618 | |
| 2018-03-06 | 2018-03-05 | PS Planned sale |
Sheehy Douglas T. See Remarks |
948
-2.8%
35.52USD 33,674 |
948 -2.8% | 35.52 | USD 33,674 | |
| 2018-03-06 | 2018-03-05 | PS Planned sale |
Sheehy Douglas T. See Remarks |
1,875
-5.5%
37.00USD 69,375 |
1,875 -5.5% | 37.00 | USD 69,375 | |
| 2018-03-05 | 2018-03-01 | PS Planned sale |
Rozenman Mary M. See Remarks |
1,807
-93.3%
33.10USD 59,812 |
1,807 -93.3% | 33.10 | USD 59,812 | |
| 2020-04-24 | 2018-02-26 | B Purchase |
Nestle Health Science US Holdings, Inc. Large shareholder |
937,500
+12.4%
32.00USD 30,000,000 |
937,500 +12.4% | 32.00 | USD 30,000,000 | |
| 2018-02-26 | 2018-02-26 | B Purchase |
BJERKHOLT ERIC Chief Financial Officer Officer |
3,125
+62.5%
32.00USD 100,000 |
3,125 +62.5% | 32.00 | USD 100,000 | |
| 2018-02-26 | 2018-02-26 | B Purchase |
FALBERG KATHRYN E Non-Executive Director |
30,000
+31.6%
32.00USD 960,000 |
30,000 +31.6% | 32.00 | USD 960,000 | |
| 2018-02-26 | 2018-02-26 | B Purchase |
Iwicki Mark T Non-Executive Director |
9,375
+46.9%
32.00USD 300,000 |
9,375 +46.9% | 32.00 | USD 300,000 | |
| 2018-02-26 | 2018-02-22 | B Purchase |
ENRIGHT PATRICK G Non-Executive Director Large shareholder |
15,593
+214.3%
32.00USD 498,976 |
15,593 +214.3% | 32.00 | USD 498,976 | |
| 2018-02-26 | 2018-02-22 | B Purchase |
Tammenoms Bakker Juliet Large shareholder |
9,375
+128.8%
32.00USD 300,000 |
9,375 +128.8% | 32.00 | USD 300,000 | |
| 2018-02-07 | 2018-02-05 | PS Planned sale |
Sheehy Douglas T. See Remarks Officer |
1,648
-100.0%
35.87USD 59,114 |
1,648 -100.0% | 35.87 | USD 59,114 | |
| 2018-02-05 | 2018-02-01 | PS Planned sale |
Rozenman Mary M. See Remarks Officer |
4,292
-97.1%
35.58USD 152,703 |
4,292 -97.1% | 35.58 | USD 152,703 | |
| 2018-02-05 | 2018-02-01 | PS Planned sale |
Rozenman Mary M. See Remarks Officer |
2,300
-34.2%
34.95USD 80,385 |
2,300 -34.2% | 34.95 | USD 80,385 | |
| 2018-01-26 | 2018-01-24 | PS Planned sale |
Sheehy Douglas T. See Remarks Officer |
1,875
-100.0%
38.15USD 71,531 |
1,875 -100.0% | 38.15 | USD 71,531 | |
| 2018-01-16 | 2018-01-16 | PS Planned sale |
ADELMAN DANIEL C MD Chief Medical Officer Officer |
9,933
-100.0%
40.00USD 397,320 |
9,933 -100.0% | 40.00 | USD 397,320 | |
| 2018-01-16 | 2018-01-12 | PS Planned sale |
ADELMAN DANIEL C MD Chief Medical Officer Officer |
26,784
-100.0%
40.00USD 1,071,360 |
26,784 -100.0% | 40.00 | USD 1,071,360 | |
| 2018-01-08 | 2018-01-04 | PS Planned sale |
Sheehy Douglas T. See Remarks Officer |
1,648
-100.0%
37.33USD 61,520 |
1,648 -100.0% | 37.33 | USD 61,520 | |
| 2018-01-04 | 2018-01-02 | PS Planned sale |
Barrowcliffe Susan E. General Manager, Europe Officer |
600
-100.0%
37.75USD 22,652 |
600 -100.0% | 37.75 | USD 22,652 | |
| 2018-01-04 | 2018-01-02 | PS Planned sale |
Barrowcliffe Susan E. General Manager, Europe Officer |
24,400
-97.6%
37.12USD 905,716 |
24,400 -97.6% | 37.12 | USD 905,716 | |
| 2018-01-04 | 2018-01-02 | PS Planned sale |
Barrowcliffe Susan E. General Manager, Europe Officer |
300
-1.2%
37.86USD 11,359 |
300 -1.2% | 37.86 | USD 11,359 | |
| 2018-01-04 | 2018-01-02 | PS Planned sale |
Barrowcliffe Susan E. General Manager, Europe Officer |
24,700
-49.4%
37.13USD 917,022 |
24,700 -49.4% | 37.13 | USD 917,022 | |
| 2018-01-04 | 2018-01-02 | PS Planned sale |
Barrowcliffe Susan E. General Manager, Europe Officer |
599
-1.2%
37.78USD 22,629 |
599 -1.2% | 37.78 | USD 22,629 | |
| 2018-01-04 | 2018-01-02 | PS Planned sale |
Barrowcliffe Susan E. General Manager, Europe Officer |
24,401
-32.5%
37.12USD 905,811 |
24,401 -32.5% | 37.12 | USD 905,811 | |
| 2018-01-04 | 2018-01-02 | PS Planned sale |
Rozenman Mary M. See Remarks Officer |
1,601
-92.5%
37.08USD 59,367 |
1,601 -92.5% | 37.08 | USD 59,367 | |
| 2018-01-04 | 2018-01-02 | PS Planned sale |
Rozenman Mary M. See Remarks Officer |
4,990
-74.3%
37.12USD 185,223 |
4,990 -74.3% | 37.12 | USD 185,223 | |
| 2017-12-29 | 2017-12-27 | PS Planned sale |
ADELMAN DANIEL C MD Chief Medical Officer |
3,283
-100.0%
40.00USD 131,320 |
3,283 -100.0% | 40.00 | USD 131,320 | |
| 2017-12-28 | 2017-12-26 | PS Planned sale |
Rozenman Mary M. See Remarks |
3,600
-96.5%
39.15USD 140,949 |
3,600 -96.5% | 39.15 | USD 140,949 | |
| 2017-12-28 | 2017-12-26 | PS Planned sale |
Rozenman Mary M. See Remarks |
6,400
-63.2%
38.73USD 247,848 |
6,400 -63.2% | 38.73 | USD 247,848 | |
| 2017-12-28 | 2017-12-26 | PS Planned sale |
Rozenman Mary M. See Remarks |
1,200
-10.6%
39.28USD 47,134 |
1,200 -10.6% | 39.28 | USD 47,134 | |
| 2017-12-28 | 2017-12-26 | PS Planned sale |
Rozenman Mary M. See Remarks |
8,800
-43.7%
38.83USD 341,663 |
8,800 -43.7% | 38.83 | USD 341,663 | |
| 2017-12-28 | 2017-12-26 | PS Planned sale |
Rozenman Mary M. See Remarks |
700
-3.4%
39.26USD 27,479 |
700 -3.4% | 39.26 | USD 27,479 | |
| 2017-12-28 | 2017-12-26 | PS Planned sale |
Rozenman Mary M. See Remarks |
4,310
-17.1%
38.80USD 167,239 |
4,310 -17.1% | 38.80 | USD 167,239 | |
| 2017-12-28 | 2017-12-26 | PS Planned sale |
Rozenman Mary M. See Remarks |
1,500
-5.6%
39.23USD 58,847 |
1,500 -5.6% | 39.23 | USD 58,847 | |
| 2017-12-28 | 2017-12-26 | PS Planned sale |
Rozenman Mary M. See Remarks |
11,000
-29.2%
38.82USD 427,043 |
11,000 -29.2% | 38.82 | USD 427,043 | |
| 2017-12-28 | 2017-12-26 | PS Planned sale |
Rozenman Mary M. See Remarks |
1,500
-3.8%
39.25USD 58,875 |
1,500 -3.8% | 39.25 | USD 58,875 | |
| 2017-12-28 | 2017-12-26 | PS Planned sale |
Rozenman Mary M. See Remarks |
11,000
-21.9%
38.83USD 427,115 |
11,000 -21.9% | 38.83 | USD 427,115 | |
| 2017-12-28 | 2017-12-26 | PS Planned sale |
Rozenman Mary M. See Remarks |
1,800
-3.5%
39.23USD 70,605 |
1,800 -3.5% | 39.23 | USD 70,605 | |
| 2017-12-28 | 2017-12-26 | PS Planned sale |
Rozenman Mary M. See Remarks |
10,700
-17.1%
38.82USD 415,322 |
10,700 -17.1% | 38.82 | USD 415,322 | |
| 2017-12-28 | 2017-12-26 | PS Planned sale |
Rozenman Mary M. See Remarks |
1,500
-2.3%
39.25USD 58,878 |
1,500 -2.3% | 39.25 | USD 58,878 | |
| 2017-12-28 | 2017-12-26 | PS Planned sale |
Rozenman Mary M. See Remarks |
11,000
-14.6%
38.83USD 427,089 |
11,000 -14.6% | 38.83 | USD 427,089 | |
| 2017-12-28 | 2017-12-26 | PS Planned sale |
Sheehy Douglas T. See Remarks |
1,875
-100.0%
39.44USD 73,950 |
1,875 -100.0% | 39.44 | USD 73,950 | |
| 2017-12-06 | 2017-12-04 | PS Planned sale |
Sheehy Douglas T. See Remarks |
1,906
-100.0%
38.66USD 73,686 |
1,906 -100.0% | 38.66 | USD 73,686 |